No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
James Januzzi, MD
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Martin Maron, MD
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Alexander Fanaroff, MD
Self-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.